J.P. Morgan’s 5 Top International Stock Picks

Photo of Lee Jackson
By Lee Jackson Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

While the U.S. markets have absolutely been on fire, the terminally slow-growth European bourses have been miserable this year for the most part, lagging domestic markets by 22% in U.S. dollar-weighted terms. Even Germany’s mighty DAX index is still trading way below the summer highs. A new research report from J.P. Morgan makes the case that the time to buy some of the top stocks in Europe is right now, not after much of the underperformance is made up.

With some forward metrics for the eurozone turning more positive, and the fact the European Union will have to rely on some consistent quantitative easing to boost growth, patient buyers may be well rewarded. Plus a falling euro versus the dollar could help exports get back on track for the top companies based there.

The J.P. Morgan list of current stocks to buy rated Overweight are all priced in euros So we will present the consensus price targets for top European stocks that can be bought and trade with liquidity here in the United States.

ASML Holding N.V. (NASDAQ: ASML) engages in designing, manufacturing, marketing and servicing semiconductor processing equipment used in the fabrication of integrated circuits or chips worldwide. It provides PAS 5500 family products that comprise wafer steppers, and step-and-scan systems suitable for the i-line, krypton fluoride, and argon fluoride processing of wafers. ASML’s guiding principle is continuing Moore’s Law toward ever smaller, cheaper, more powerful and energy-efficient semiconductors.

ASML investors are paid a small 0.7% dividend. The Thomson/First Call consensus price target for the stock is $93.71. The stock closed way above that Tuesday at $103.86.

ALSO READ: 7 Analyst Stock Picks Under $10 With Massive Upside Calls

ING Groep N.V. (NYSE: ING) provides banking, investment, life insurance and retirement services for individuals, families, small businesses, large corporations, institutions and governments. It operates through Retail Netherlands, Retail Belgium, Retail Germany, Retail Rest of the World, Commercial Banking, Netherland Life, Netherland Non-Life, Insurance Europe, Japan Life, Investment Management, Other and Japan Closed Block VA segments. The company accepts various deposits products, such as current and savings accounts, and offers business lending, mortgages, consumer lending, cash management, corporate finance, real estate and lease products.

The consensus price target for this top financial stock is $14.71. Shares closed Tuesday at $14.28.

Nokia Corp. (NYSE: NOK) was once the biggest smartphone maker in the world, but it was slow to adapt to the new generation of devices that came along after the iPhone launched in 2007. Android phones eventually dominated the global market, but Nokia made the decision to use the Windows Phone software for its top-tier devices. Microsoft bought the company’s devices and services division last year for $7.2 billion, and it freed the company from its downward spiral in the cellphone industry. Nokia recently announcing its business outlook for 2015, and the revamped telecommunications equipment company stated that it expects sales at its Nokia Networks division to grow over the 2014 levels.

The consensus price target is $9.59, and shares closed trading on Tuesday at $7.93.

ALSO READ: 5 Top Retail Stock Picks for the Holiday Shopping Season

Novartis A.G. (NYSE: NVS) is actually the world’s biggest drug maker by sales and is also is the manufacturer of the fourth top-selling oncology drug in the world, Gleevec. The drug had $4.7 billion in sales but is showing 0% year-over year sales growth, which could prove troubling for Novartis, as physicians could be switching patients to other treatments and drugs. The company released LCZ696 data in the summer, and it is one of the top pipeline prospects. The drug is an investigational combination drug consisting of two blood pressure lowering drugs: valsartan and AHU-377. The Wall Street buzz is the drug could be a blockbuster for Novartis.

Novartis investors receive a 2.9% dividend. The consensus price target is $100.09. Novartis closed Monday at $95.58 a share.

Royal Dutch Shell PLC (NYSE: RDS-A) operates as an independent oil and gas company worldwide. The company explores for and extracts crude oil, natural gas and natural gas liquids. It also converts natural gas to liquids to provide fuels and other products. Shell recently won a significant victory recently in its ongoing $3 billion fight with India’s revenue authorities, in a judgment with implications for dozens of tax disputes involving multinational companies in Asia’s third-largest economy. Any lift in the energy market next year could make this a top stock to own.

Royal Dutch Shell investors are paid a very solid 4.7% dividend. The consensus price target for the oil giant was not posted. Shares closed Tuesday at $70.03.

ALSO READ: UBS Updates Quality Growth at a Reasonable Price Stock List

On many metrics, the U.S. markets are fully valued. Taking some money off the table now and looking for bargains in these top European stocks that trade with liquidity here at home could make good sense for long-term growth investors.

Photo of Lee Jackson
About the Author Lee Jackson →

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad and diverse career, which included a stint as the creative services director at the NBC affiliate in Austin, Texas, gives him unique insight into the financial industry and world.

Lee Jackson's journey in the financial industry spans over 30 years, with nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career was marked by his presence on the sell side during pivotal Wall Street events, from the dot.com rise and bubble to the Long Term Capital Management debacle, 9/11, and the Great Recession of 2008. This is a testament to his resilience and adaptability in the face of market volatility.

Lee Jackson’s practical financial industry experience, acquired from a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing on various platforms. This unique combination allows him to shed light on the intricacies and workings of Wall Street in a way that only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618